3.9 Article

Mapping Antigenic Motifs in the Trypomastigote Small Surface Antigen from Trypanosoma cruzi

Journal

CLINICAL AND VACCINE IMMUNOLOGY
Volume 22, Issue 3, Pages 304-312

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00684-14

Keywords

-

Funding

  1. ANPCyT
  2. Fundacion Bunge y Born
  3. Consejo Inter-Universitario Nacional (Argentina)
  4. Ministry of Health (Argentina)
  5. Argentinean Research Council (CONICET)

Ask authors/readers for more resources

The trypomastigote small surface antigen (TSSA) is a mucin-like molecule from Trypanosoma cruzi, the etiological agent of Chagas disease, which displays amino acid polymorphisms in parasite isolates. TSSA expression is restricted to the surface of infective cell-derived trypomastigotes, where it functions as an adhesin and engages surface receptors on the host cell as a prerequisite for parasite internalization. Previous results have established TSSA-CL, the isoform encoded by the CL Brener clone, as an appealing candidate for use in serology-based diagnostics for Chagas disease. Here, we used a combination of peptide-and recombinant protein-based tools to map the antigenic structure of TSSA-CL at maximal resolution. Our results indicate the presence of different partially overlapping B-cell epitopes clustering in the central portion of TSSA-CL, which contains most of the polymorphisms found in parasite isolates. Based on these results, we assessed the serodiagnostic performance of a 21-amino-acid-long peptide that spans TSSA-CL major antigenic determinants, which was similar to the performance of the previously validated glutathione S-transferase (GST)-TSSA-CL fusion molecule. Furthermore, the tools developed for the antigenic characterization of the TSSA antigen were also used to explore other potential diagnostic applications of the anti-TSSA humoral response in Chagasic patients. Overall, our present results provide additional insights into the antigenic structure of TSSA-CL and support this molecule as an excellent target for molecular intervention in Chagas disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Review of pharmacological options for the treatment of Chagas disease

Fernanda Lascano, Facundo Garcia Bournissen, Jaime Altcheh

Summary: Chagas disease is a global problem with limited treatment options, highlighting the need for further research on treatment response biomarkers to guide new drug development efforts.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Infectious Diseases

Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO)

Jaime Altcheh, Luis Castro, Juan C. Dib, Ulrike Grossmann, Erya Huang, Guillermo Moscatelli, Jimy Jose Pinto Rocha, Teresa Estela Ramirez

Summary: Nifurtimox showed good efficacy, safety, and tolerability in treating children with Chagas disease, especially with a 60-day treatment period showing superior serological response. However, the shorter 30-day treatment regimen had lower efficacy compared to the 60-day regimen.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Oncology

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

Fernanda G. Herrera, Catherine Ronet, Maria Ochoa de Olza, David Barras, Isaac Crespo, Massimo Andreatta, Jesus Corria-Osorio, Aodrenn Spill, Fabrizio Benedetti, Raphael Genolet, Angela Orcurto, Martina Imbimbo, Eleonora Ghisoni, Blanca Navarro Rodrigo, Dominik R. Berthold, Apostolos Sarivalasis, Khalil Zaman, Rafael Duran, Clarisse Dromain, John Prior, Niklaus Schaefer, Jean Bourhis, Georgia Dimopoulou, Zoi Tsourti, Marius Messemaker, Thomas Smith, Sarah E. Warren, Periklis Foukas, Sylvie Rusakiewicz, Mikael J. Pittet, Stefan Zimmermann, Christine Sempoux, Urania Dafni, Alexandre Harari, Lana E. Kandalaft, Santiago J. Carmona, Denarda Dangaj Laniti, Melita Irving, George Coukos

Summary: Developing strategies to inflame tumors is critical for increasing response to immunotherapy. Low-dose radiation reprograms the tumor microenvironment to promote T-cell infiltration and, when combined with immunotherapy, simultaneously mobilizes innate and adaptive immunity, predominantly CD4(+) effector T cells, for tumor control dependent on NKG2D. This combination induces important responses in patients with metastatic immune-cold tumors.

CANCER DISCOVERY (2022)

Article Biochemistry & Molecular Biology

Characterization of ADAT2/3 molecules in Trypanosoma cruzi and regulation of mucin gene expression by tRNA editing

Santiago Bertotti, Ian Fleming, Maria de los Milagros Camara, Camila Centeno Camean, Santiago J. Carmona, Fernan Aguero, Virginia Balouz, Astrid Zahn, Javier M. Di Noia, Juan D. Alfonzo, Carlos A. Buscaglia

Summary: This study identified and characterized the ADAT molecules from the protozoan pathogen Trypanosoma cruzi, and found that they play an important role in tRNA editing and gene expression, revealing differences between parasite and mammalian host tRNA editing and processing.

BIOCHEMICAL JOURNAL (2022)

Article Biochemistry & Molecular Biology

SPICA: Swiss portal for immune cell analysis

Massimo Andreatta, Fabrice P. A. David, Christian Iseli, Nicolas Guex, Santiago J. Carmona

Summary: Single-cell transcriptomics enables the study of immune cell heterogeneity at an unprecedented resolution. SPICA, the Swiss portal for immune cell analysis, is a web resource dedicated to exploring and analyzing single-cell RNA-seq data of immune cells, providing curated reference atlases and allowing users to contribute to the database.

NUCLEIC ACIDS RESEARCH (2022)

Article Microbiology

Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults

N. Falk, A. J. Berenstein, G. Moscatelli, S. Moroni, N. Gonzalez, G. Ballering, H. Freilij, J. Altcheh

Summary: A retrospective study evaluated the treatment response of a large cohort of children and adults with Chagas disease treated with nifurtimox. The results showed that nifurtimox was highly effective in treating Chagas disease, with patients having excellent treatment responses and resolution of symptoms related to acute Trypanosoma cruzi infection. Clearance of parasitemia and a decrease in T. cruzi antibodies were observed as markers of treatment response. Younger patients showed a higher rate of seroconversion, indicating a more marked treatment response.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Biochemical Research Methods

scGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets

Massimo Andreatta, Ariel J. Berenstein, Santiago J. Carmona

Summary: scGate is a bioinformatics task in single-cell data analysis that automates the purification of a cell type or cell population of interest. It uses a set of markers to purify the cell population and outperforms other single-cell classifiers. scGate can be applied to multiple modalities of single-cell data and is integrated with the Seurat framework, providing an intuitive tool.

BIOINFORMATICS (2022)

Article Infectious Diseases

Evaluation of Toxoplasma gondii recombinant antigens for early diagnosis of congenital toxoplasmosis

Elias M. Rivera, Guillermo Moscatelli, Griselda Ballering, Agustina Ganuza, Andres M. Alonso, Samanta Moroni, Marina Clemente, Jaime Altcheh, Sergio O. Angel

Summary: The performance of Toxoplasma rGra8, rMic1, and the chimeric rGra4-Gra7 antigens for early congenital toxoplasmosis (CT) diagnosis was evaluated. Sera from CT patients showed high IgG reactivity to rMic1, rGra8, and rGra4-Gra7. The seroreactivity of samples from uninfected infants was lost within 2 months of age.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2022)

Article Biochemical Research Methods

Metacells untangle large and complex single-cell transcriptome networks

Mariia Bilous, Loc Tran, Chiara Cianciaruso, Aurelie Gabriel, Hugo Michel, Santiago J. Carmona, Mikael J. Pittet, David Gfeller

Summary: SuperCell is a framework that efficiently combines highly similar cells into metacells, preserving and accelerating the results of single-cell RNA sequencing data analysis.

BMC BIOINFORMATICS (2022)

Article Biochemistry & Molecular Biology

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Jana Biermann, Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay A. Caprio, Alcida Karz, Somnath Tagore, Irving Barrera, Miguel A. Ibarra-Arellano, Massimo Andreatta, Benjamin T. Fullerton, Kristjan H. Gretarsson, Varun Sahu, Vaibhav S. Mangipudy, Trang T. T. Nguyen, Ajay Nair, Meri Rogava, Patricia Ho, Peter D. Koch, Matei Banu, Nelson Humala, Aayushi Mahajan, Zachary H. Walsh, Shivem B. Shah, Daniel H. Vaccaro, Blake Caldwell, Michael Mu, Florian Wuennemann, Margot Chazotte, Simon Berhe, Adrienne M. Luoma, Joseph Driver, Matthew Ingham, Shaheer A. Khan, Suthee Rapisuwon, Craig L. Slingluff, Thomas Eigentler, Martin Roecken, Richard Carvajal, Michael B. Atkins, Michael A. Davies, Albert Agustinus, Samuel F. Bakhoum, Elham Azizi, Markus Siegelin, Chao Lu, Santiago J. Carmona, Hanina Hibshoosh, Antoni Ribas, Peter Canoll, Jeffrey N. Bruce, Wenya Linda Bi, Praveen Agrawal, Denis Schapiro, Eva Hernando, Evan Z. Macosko, Fei Chen, Gary K. Schwartz, Benjamin Izar

Summary: This study provides comprehensive insights into the biology of melanoma brain metastasis (MBM) and reveals the distinct characteristics of cancer cells in MBM, including chromosomal instability and neuronal-like cell state. The study also identifies the presence of monocyte-derived macrophages and dysfunctional T cells in MBM, as well as the geographic differences in cancer immune evasion. These findings contribute to a better understanding of MBM and have implications for future therapeutic exploration.
Article Biology

A CD4+ T cell reference map delineates subtype-specific adaptation during acute and chronic viral infections

Massimo Andreatta, Ariel Tjitropranoto, Zachary Sherman, Michael C. Kelly, Thomas Ciucci, Santiago J. Carmona

Summary: This study utilized single-cell transcriptomics to characterize the diversity of CD4(+) T cells responding to viral infections and built a comprehensive map of their transcriptional states. The research revealed the progressive changes in CD4(+) T cell subtypes during acute infections and identified distinct programs associated with chronic infections. Additionally, the study demonstrated the private nature of virus-specific CD4(+) T cell responses across individuals and their differentiation into Tfh and Th1 subtypes. Moreover, the CD4(+) T cell map developed in this study can be used to interpret cell states in other single-cell datasets.

ELIFE (2022)

Article Microbiology

Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)

Jaime Altcheh, Victor Sierra, Teresa Ramirez, Jimy Jose Pinto Rocha, Ulrike Grossmann, Erya Huang, Guillermo Moscatelli, Olivia Ding

Summary: This study confirms the effectiveness and safety of a pediatric formulation of nifurtimox administered in an age- and weight-adjusted regimen for 60 days to treat children with Chagas disease.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Immunology

Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells

Jesus Corria-Osorio, Santiago J. J. Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A. A. Rota, Isaac Crespo, Bili Seijo, Wilson Castro, Cristina Jimenez-Luna, Leonardo Scarpellino, Catherine Ronet, Aodrenn Spill, Evripidis Lanitis, Pedro Romero, Sanjiv A. A. Luther, Melita Irving, George Coukos

Summary: Coukos, Corria-Osorio and colleagues have used a genetic engineering approach to improve the effectiveness of CD8(+) T cells in antitumor cell therapy. They engineered these cells to express an IL-2 variant, IL-33 and a programmed cell death protein 1 decoy. The results showed that these engineered cells had enhanced effector functions and were able to overcome exhaustion and control tumors.

NATURE IMMUNOLOGY (2023)

Meeting Abstract Oncology

Dissecting the ecosystem of treatment-naive melanoma brain metastasis using multi-modal singlecell analysis

Johannes C. Melms, Jana Biermann, Amit Dipak Amin, Yiping Wang, Somnath Tagore, Massimo Andreatta, Ajay Nair, Meri Rogava, Patricia Ho, Lindsay A. Caprio, Zachary H. Walsh, Shivem Shah, Daniel H. Vacarro, Blake Caldwell, Adrienne M. Luoma, Joseph Driver, Matthew Ingham, Suthee Rapisuwon, Jennifer Wargo, Craig L. Slinguff, Evan Z. Macosco, Fei Chen, Richard Carvajal, Michael B. Atkins, Michael A. Davies, Elham Azizi, Santiago J. Carmona, Hanina Hibshoosh, Peter D. Canoll, Jeffrey N. Bruce, Wenya L. Bi, Gary K. Schwartz, Benjamin Izar

CANCER RESEARCH (2022)

Article Cell Biology

Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting

Julien Schmidt, Angela R. Smith, Morgane Magnin, Julien Racle, Jason R. Devlin, Sara Bobisse, Julien Cesbron, Victor Bonnet, Santiago J. Carmona, Florian Huber, Giovanni Ciriello, Daniel E. Speiser, Michal Bassani-Sternberg, George Coukos, Brian M. Baker, Alexandre Harari, David Gfeller

Summary: CD8+ T cell recognition of peptide epitopes is crucial in immune responses, but the rules governing which peptides are recognized by T cell receptors remain unclear. Training a predictor called PRIME using recent epitope data improves prediction accuracy, particularly in cancer immunotherapy for identifying new epitopes.

CELL REPORTS MEDICINE (2021)

No Data Available